Aristotle University Of Thessaloniki (AUTH)
Σχεδιασμός, σύνθεση και φαρμακοχημική μελέτη νέων υβριδικών παραγώγων με πιθανή βιολογική δράση
Abstract
dc:descriptionNowadays the research of pleiotropic hybrid molecules is flourishing. Hybridmolecules are products of rational design bearing two or more pharmacophoremoieties in a single molecule, presenting a unique interest on the treatment ofcomplex diseases replacing common therapeutic approaches which include thesimultaneously usage of several drugs.In this dissertation we dealt with two distinct classes of hybrid multifunctionalmolecules. The design of these molecules whom was based on the most recentliterature data and the crystallographic data of the enzymes LOX, COX-2, Trypsin,ATX, PDE-2, DNA GyrB, topoIV ParE taken from the PDB.The first group includes hybrid derivatives of babrituric/thiobarbituric acid.The pyrimidine-2,4,6(1H,3H,5H)-trione and 2-thioxo-dihydropyrimidine4,6(1H,5H)-dionewere combined with various biologically active moieties through aKnoevenagel condensation. The products compiled a novel library that was subjectedto docking simulations over the protein X-ray data (LOX, COX-2, trypsin, ATX andPDE-2). Molecules that showed a multifunctional profile have been chosen to bechemically synthesized and biologically studied over the selected biological targets. The second group is consisted by hybrid molecules, analogues of the alkaloidOroidin, which is known for its antibacterial activity against Gram (+) bacteria.Computer aided drug design techniques were applied which in combination withLBDD and SBDD pointed to the more suitable derivatives, bearing differentpharmacophores linked via a peptide bond and an unsaturated chain, introducing theoroidin flexible aminoimidazole ending replacement by rigidified heterocyclic ringsthat maintained the free amine. The compiled library of molecules was screened fortheir binding over the E. coli DNA GyrB crystal data. The structures with the lowestscoring function were selected to be synthesized.The synthesis of the novel compounds was based on the implementation ofknown and modified procedures and techniques in an attempt to have efficient yields.All the compounds were purified through various techniques and identified bycontemporary spectrometric analysis.Through this study, the physicochemical properties (molar volume,stereochemistry) that are significant and optimum for the biological activities of thenovel hybrids, were found. The derivatives were studied in vitro over all the selectedbiological targets. Their antioxidant activities were determined as well.The biological results confirm that compounds TH35, TH19, TH31, TH36 andLJ39 are pleiotropic hybrid derivatives. Especially, compound TH35 constitutes apotent inhibitor for the enzymes LOX, COX-2 and PDE-2.Compounds TH19 and TH31 were found to be potent inhibitors of trypsin, COX-2, ATX, whereas compound TH36 exhibited a potent inhibitory activity ofCOX-2 with satisfactory neuroprotection over the HT22 cell line. Their antioxidantproperties explain in part their inhibitory activity over LOX and COX-2.Analogues of oroidin of the series LJ, were studied for their bacterial inhibitionon E. coli and S. aureus strains of DNA gyrase and Topo IV. LJ39 presents an exceptional interest as pleiotropic molecule (potent inhibitor of COX-2) whilecompound LJ24 strongly inhibits trypsin.Hybrid molecule TH18 resulted to a 24h tolerance of pain induced by a heatstimuli.Compounds TH18, TH19 and TH16 through their physicochemical propertiesare presenting the best "druglikeness profile".
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Katsamakas, Sotirios
- Κατσαμάκας, Σωτήριος
Subjects
dc:subject × 16- Αντιφλεγμονώδη
- Αντιβακτηριακά
- Υβριδικά μόρια
- Υπολογιστικά υποβοηθούμενος σχεδιασμός φαρμάκων
- Anti-inflammatory
- Anti-bacterials
- Hybrid molecules
- Computer aided drug design
- Φυσικές Επιστήμες
- Χημεία
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Natural Sciences
- Chemical Sciences
- Medical and Health Sciences
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/43542